The agency said it would work in the coming months to explore policy options.
- Fluidx Medical Introduces New Ultra Embolic Platform
- Effective ‘People Strategy’ for Start-Ups
- This Disappearing Heart Device Disappeared Altogether
- Surviving the Headwinds in Medical Device Manufacturing
- Medtronic Makes a Double Play for Atrial Fibrillation
- Pulse Biosciences files 510(k) for CellFX nsPFA Percutaneous Electrode